688266 澤璟製藥
按盤價 
110.340 -0.980 (-0.880%) | 2025/09 - 九個月 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | -7.775 | -9.549 | -23.293 | -46.775 | -32.053 |
| 總資產報酬率 ROA (%) | -3.105 | -4.679 | -12.231 | -26.789 | -24.272 |
| 投入資產回報率 ROIC (%) | -3.546 | -5.313 | -14.257 | -33.181 | -28.859 | 邊際利潤分析 |
| 銷售毛利率 (%) | 90.404 | 93.059 | 92.441 | 91.346 | 96.707 |
| 營業利潤率 (%) | -16.305 | -29.091 | -77.058 | -160.618 | -241.145 |
| 息稅前利潤/營業總收入 (%) | -20.764 | -34.567 | -81.244 | -165.924 | -262.516 |
| 淨利潤/營業總收入 (%) | -16.109 | -28.201 | -76.373 | -160.601 | -242.693 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 128.959 | 125.086 | 131.168 | 107.252 | 109.426 |
| 價值變動淨收益/利潤總額(%) | -1.064 | -4.423 | -4.910 | -1.349 | -2.752 |
| 營業外收支淨額/利潤總額(%) | 1.584 | 0.003 | 0.435 | 0.491 | 1.312 | 償債能力分析 |
| 流動比率 (X) | 1.850 | 1.876 | 2.220 | 1.772 | 3.691 |
| 速動比率 (X) | 1.721 | 1.742 | 2.123 | 1.636 | 3.555 |
| 資產負債率 (%) | 61.870 | 58.311 | 43.030 | 52.797 | 28.230 |
| 帶息債務/全部投入資本 (%) | 42.536 | 38.954 | 32.749 | 34.824 | 8.893 |
| 股東權益/帶息債務 (%) | 101.266 | 123.730 | 192.701 | 165.078 | 936.788 |
| 股東權益/負債合計 (%) | 61.630 | 71.567 | 131.430 | 86.183 | 242.721 |
| 利息保障倍數 (X) | 4.948 | 6.314 | 21.108 | 36.770 | 14.452 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 73.158 | 82.559 | 88.559 | 90.121 | 117.952 |
| 存貨周轉天數 (天) | 846.880 | 1,429.207 | 1,292.941 | 1,038.189 | 2,154.996 |
| 備註： | 即時報價更新時間為 05/12/2025 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
